GNBT>>>Breast cancer vaccine, Bloomberg segment on Generex was aired this week, huge accumulation going on...need I say more?

http://quotes.freerealtime.com/dl/frt/N?NewsStory=1

GNBT...PRE-MARKET bids are going up. Something is up after yesterday's huge block trades at ask. Accumulation is in progress, this is a $$$$$$$ stock, but you can buy it now for 17 cents. Jump in, do not delay. This is one of the few penny stocks that you can invest in...flippers are not welcomed! LOL

GNBT...PRE-MARKET bids are going up. Something is up after yesterday's huge block trades at ask. Accumulation is in progress, this is a $$$$$$$ stock, but you can buy it now for 17 cents. Jump in, do not delay. This is one of the few penny stocks that you can invest in...flippers are not welcomed! LOL

GNBT>>>was on Bloomberg TV 2 days ago, had a great exposure for everyone to see. Company is working on a breast cancer vaccine and making great strides. This is a multi-dollar stock, and you can buy it now for 16 cents. Should I go on?

GNBT>>>was on Bloomberg TV 2 days ago, had a great exposure for everyone to see. Company is working on a breast cancer vaccine and making great strides. This is a multi-dollar stock, and you can buy it now for 16 cents. Should I go on?

GNBT>>>WOW>>>buys are pouring in now, don't delay jumping in!!!

GNBT>>>WOW>>>buys are pouring in now, don't delay jumping in!!!

GNBT>>>Stock is taking off right now!!!!

GNBT>>>For those that have not as of now invested in this stock, and I mean INVESTED, do it NOW. Breast cancer vaccine is being developed by this company.... should I say more. Day trade other stocks, invest in this one!

http://www.bloomberg.com/video/83137924/

GNBT>>>For those that have not as of now invested in this stock, and I mean INVESTED, do it NOW. Breast cancer vaccine is being developed by this company.... should I say more. Day trade other stocks, invest in this one!

http://www.bloomberg.com/video/83137924/

Generex Announces Airing of Antigen Express Breast Cancer Vaccine Segment on Bloomberg Television - Wednesday, December 21, 2011

WORCESTER, Mass. and TORONTO, Dec. 21, 2011 /PRNewswire/ -- Generex Biotechnology Corporation (OTCBB: GNBT.OB) today announced that the previously announced Bloomberg Television segment on the Antigen Express breast cancer vaccine aired yesterday evening (December 20, 2011). The segment can be viewed on the Company's website at www.generex.com or on the Bloomberg website at http://www.bloomberg.com/video/83137924/.

(Logo: http://photos.prnewswire.com/prnh/20110106/NY25057LOGO-b)

About Generex Biotechnology Corporation
Generex is engaged in the research, development, and commercialization of drug delivery systems and technologies. Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity (with no deposit in the lungs). The Company's proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using the Company's proprietary RapidMist™ device. Antigen Express, Inc. is a wholly owned subsidiary of Generex. The core platform technologies of Antigen Express comprise immunotherapeutic vaccines for the treatment of malignant, infectious, allergic, and autoimmune diseases. Antigen Express has pioneered the use of specific CD4+ T-helper stimulation in immunotherapy. One of its platform technologies relies on inhibition of expression of the Ii protein. Antigen Express scientists, and others, have shown clearly that suppression of expression of the Ii protein in cancer cells allows for potent stimulation of T-helper cells and prevents the further growth of cancer cells. For more information, visit the Generex website at www.generex.com or the Antigen Express website at www.antigenexpress.com.

GNBT>>>>>Generex Announces Airing of Antigen Express Breast Cancer Vaccine Segment on Bloomberg Television - Wednesday, December 21, 2011

WORCESTER, Mass. and TORONTO, Dec. 21, 2011 /PRNewswire/ -- Generex Biotechnology Corporation (OTCBB: GNBT.OB) today announced that the previously announced Bloomberg Television segment on the Antigen Express breast cancer vaccine aired yesterday evening (December 20, 2011). The segment can be viewed on the Company's website at www.generex.com or on the Bloomberg website at http://www.bloomberg.com/video/83137924/.

(Logo: http://photos.prnewswire.com/prnh/20110106/NY25057LOGO-b)

About Generex Biotechnology Corporation
Generex is engaged in the research, development, and commercialization of drug delivery systems and technologies. Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity (with no deposit in the lungs). The Company's proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using the Company's proprietary RapidMist™ device. Antigen Express, Inc. is a wholly owned subsidiary of Generex. The core platform technologies of Antigen Express comprise immunotherapeutic vaccines for the treatment of malignant, infectious, allergic, and autoimmune diseases. Antigen Express has pioneered the use of specific CD4+ T-helper stimulation in immunotherapy. One of its platform technologies relies on inhibition of expression of the Ii protein. Antigen Express scientists, and others, have shown clearly that suppression of expression of the Ii protein in cancer cells allows for potent stimulation of T-helper cells and prevents the further growth of cancer cells. For more information, visit the Generex website at www.generex.com or the Antigen Express website at www.antigenexpress.com.

GNBT>>>EXPLODING!!!!

GNBT>>>Buys are pouring in right now on Bloomberg's segment about Generex's breast cancer vaccine!

GNBT>>>Buys are pouring in right now on Bloomberg's segment about Generex's breast cancer vaccine!

GNBT>>>Bloomberg TV aired last night segment about GNBT's breast cancer vaccine...GO GENEREX!!!

http://www.bloomberg.com/video/83137924/

GNBT>>>Bloomberg TV aired last night segment about GNBT's breast cancer vaccine...GO GENEREX!!!

http://www.bloomberg.com/video/83137924/

New PR from the company about Bloomberg...

http://quotes.freerealtime.com/dl/frt/N?NewsStory=1

http://quotes.freerealtime.com/dl/frt/M?IM=quotes&type=Profile&symbol=gnbt&qm_page=42529

From Yahoo board...

"Just received this back from the company......... 1 minute ago
Hello Mike

The segment was not on last night. We have full confidence it will run at a later date. Bloomberg did run a promo on the story http://i879.photobucket.com/albums/ab357... – we will let our investors know when to expect to see this story.



Thanks Todd Falls "

MARK FLETCHER ANNOUNCES BLOOMBERG FOR THURSDAY!

GNBT....Bloomberg video on Antigen Express

gnbt....Bloomberg video on Antigen Express/GNBT

GNBT>>>Pivot Point 2nd Level Resistance

0.1975

Pivot Point 1st Level Resistance

0.1867

After second level sky is the limit! IMO

GNBT>>>"nuff" said!

http://finance.yahoo.com/news/Breast-Cancer-Vaccine-Being-prnews-1006600732.html?x=0

GNBT>>>"nuff" said!

http://finance.yahoo.com/news/Breast-Cancer-Vaccine-Being-prnews-1006600732.html?x=0

GNBT>>>This is a dollar stock in the short run! Now it's at .16

GNBT>>>WOW>>>Read the news!

WORCESTER, Mass. and TORONTO, Dec. 19, 2011 /PRNewswire via COMTEX/ -- Generex Biotechnology Corporation (OTCBB:GNBT.OB) today announced that Bloomberg Television is scheduled to air a segment on the immunotherapeutic breast cancer vaccine being developed by its wholly-owned subsidiary, Antigen Express, Inc. The segment is scheduled to air at 6 pm EST (3 pm PST) today, Monday, December 19, 2011 (see promo at http://i879.photobucket.com/albums/ab357/tc2000chartreader/72389a92.mp4. It is expected that, once aired, the segment will be available for viewing on the Bloomberg website and on the Generex website.

(Logo: http://photos.prnewswire.com/prnh/20110106/NY25057LOGO-b )

The story will cover the Company's novel Ii-Key Hybrid-based HER-2/neu Peptide Vaccine (AE37), which is the subject of an ongoing Phase 2 clinical study in patients with HER-2 expressing breast cancer. The segment will be featured in Bloomberg's "Innovators" segment, which focuses on world-changing technologies and innovations.

The segment will include an interview by Bloomberg reporter Cali Carlin of Dr. Eric von Hofe, Ph.D., President of Antigen Express, and COL George E. Peoples, MD, FACS, Director, Cancer Vaccine Development Program.

Antigen Express has pioneered technology for increasing the potency of therapeutic anti-cancer vaccines. Initial clinical studies showed that its lead compound, AE37, indeed showed surprisingly potent immunological activity without sacrificing any specificity in the immune response. For the last four years, AE37 has been in a controlled, randomized Phase II study to determine whether it can indeed prevent recurrences in patients who have had breast cancer. Positive interim results from that study were recently presented at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS). Final Phase 2 results are expected in 2012.

The Antigen Express AE37 breast cancer vaccine was also featured in Newsweek magazine on December 12, 2011 in science columnist and science editor Sharon Begley's article, Could This Be The End of Cancer?:(http://www.thedailybeast.com/newsweek/2011/12/11/could-this-be-the-end-of-cancer.html).";

GNBT>>>WOW>>>Read the news!

WORCESTER, Mass. and TORONTO, Dec. 19, 2011 /PRNewswire via COMTEX/ -- Generex Biotechnology Corporation (OTCBB:GNBT.OB) today announced that Bloomberg Television is scheduled to air a segment on the immunotherapeutic breast cancer vaccine being developed by its wholly-owned subsidiary, Antigen Express, Inc. The segment is scheduled to air at 6 pm EST (3 pm PST) today, Monday, December 19, 2011 (see promo at http://i879.photobucket.com/albums/ab357/tc2000chartreader/72389a92.mp4. It is expected that, once aired, the segment will be available for viewing on the Bloomberg website and on the Generex website.

(Logo: http://photos.prnewswire.com/prnh/20110106/NY25057LOGO-b )

The story will cover the Company's novel Ii-Key Hybrid-based HER-2/neu Peptide Vaccine (AE37), which is the subject of an ongoing Phase 2 clinical study in patients with HER-2 expressing breast cancer. The segment will be featured in Bloomberg's "Innovators" segment, which focuses on world-changing technologies and innovations.

The segment will include an interview by Bloomberg reporter Cali Carlin of Dr. Eric von Hofe, Ph.D., President of Antigen Express, and COL George E. Peoples, MD, FACS, Director, Cancer Vaccine Development Program.

Antigen Express has pioneered technology for increasing the potency of therapeutic anti-cancer vaccines. Initial clinical studies showed that its lead compound, AE37, indeed showed surprisingly potent immunological activity without sacrificing any specificity in the immune response. For the last four years, AE37 has been in a controlled, randomized Phase II study to determine whether it can indeed prevent recurrences in patients who have had breast cancer. Positive interim results from that study were recently presented at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS). Final Phase 2 results are expected in 2012.

The Antigen Express AE37 breast cancer vaccine was also featured in Newsweek magazine on December 12, 2011 in science columnist and science editor Sharon Begley's article, Could This Be The End of Cancer?:(http://www.thedailybeast.com/newsweek/2011/12/11/could-this-be-the-end-of-cancer.html).";

GNBT>>>Exploding!!!

GNBT>>>Exploding!!!

GNBT>>>Huge hits at ask, 95% of trades are buys. Monday is "Post Time"

GNBT>>>Huge hits at ask, 95% of trades are buys. Monday is "Post Time"

GNBT>>>Nice hits, one for 50k and two for 20k at ask. Starting to take off before Monday's Bloomberg and Newsweek's exposure.

GNBT>>>Nice hits, one for 50k and two for 20k at ask. Starting to take off before Monday's Bloomberg and Newsweek's exposure.

GNBT>>>Slowely but surely buys are coming in at ask. Monday GNBT will be on Bloomberg TV, and also featured in Newsweek Magazine. Get in now, this is a wonderfull opportunity to get in at this prices, since SKY is the limit!!!

http://finance.yahoo.com/news/Breast-Cancer-Vaccine-Being-prnews-2837270956.html?x=0

GNBT>>>Slowely but surely buys are coming in at ask. Monday GNBT will be on Bloomberg TV, and also featured in Newsweek Magazine. Get in now, this is a wonderfull opportunity to get in at this prices, since SKY is the limit!!!

http://finance.yahoo.com/news/Breast-Cancer-Vaccine-Being-prnews-2837270956.html?x=0

GNBT>>>Monday, Dec. 19th this company will be featured on Bloomberg TV and Newsweek magazine. "Nuff" said!!!

GNBT>>>Monday, Dec. 19th this company will be featured on Bloomberg TV and Newsweek magazine. "Nuff" said!!!

GNBT>>>Starting to rebound right now...this is a multi bagger in the making. Company is going to be on Bloomberg TV this coming Monday!


http://finance.yahoo.com/news/Breast-Cancer-Vaccine-Being-prnews-2837270956.html?x=0